Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Clin Exp Neuropsychol ; 37(9): 981-7, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26332177

RESUMO

INTRODUCTION: Huntington's disease (HD) is a genetic, neurodegenerative disease that affects cognitive, psychiatric and motor functioning. Frontal subcortical circuits are impacted by disease pathology, resulting in frontally mediated behavioral dysfunction. The purpose of this study was (a) to examine the relationship between both patient and informant reports of frontally mediated behaviors and disease progression and (b) to determine rate of agreement between patient and informant reports of these behaviors in relation to disease progression. METHOD: Twenty-six HD patients and their informants participated in the study at the University of South Florida. Patient-informant pairs completed the Frontal Systems Behavior Scale (FrSBe) Self and Family ratings forms, respectively. UHDRS (Unified Huntington's Disease Rating Scale) motor scores were obtained from medical records as an index of disease progression. RESULTS: Only informant report of frontally mediated behaviors of apathy, disinhibition, and executive dysfunction was related to neurological examination results. On average, ratings by patients with less severe motor symptoms were comparable to informant ratings, suggesting intact awareness of deficits. In contrast, ratings of patients with more severe motor symptoms were discrepant from informant data, with informants providing more severe ratings than patients. CONCLUSIONS: HD patients may show intact awareness of frontally mediated behaviors in less severe stages but become increasingly unaware in more severe stages of the disease. This underscores the importance of clinical decisions regarding patient versus informant report at various stages of the disease.


Assuntos
Conscientização/fisiologia , Transtornos Cognitivos/etiologia , Doença de Huntington/complicações , Doença de Huntington/psicologia , Transtornos Mentais/etiologia , Adulto , Idoso , Antipsicóticos/uso terapêutico , Progressão da Doença , Feminino , Lobo Frontal/patologia , Haloperidol/uso terapêutico , Humanos , Doença de Huntington/diagnóstico , Doença de Huntington/tratamento farmacológico , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Risperidona/uso terapêutico , Índice de Gravidade de Doença
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...